
HPLC Verified
Research Grade
COA Published
Tirzepatide 60mg
Tirzepatide
CAS: 2023788-19-2
Dual GLP-1/GIP receptor agonist. 99.2% purity. 60mg bulk research vial; SURMOUNT-1 Phase 3 −20.9% body weight; designed for extended comparative or multi-subject studies.
Price
$399.99
20 in stock
HPLC verified · third-party tested · research use only
Specifications
Tirzepatide — Research Overview
Dual GLP-1/GIP receptor agonist. 99.2% purity. 60mg bulk research vial; SURMOUNT-1 Phase 3 −20.9% body weight; designed for extended comparative or multi-subject studies.
Related Products

Semaglutide 3mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Starter 3mg vial suited to initial dose-titration research; STEP-1 trial recorded −14.9% mean body weight at 68 weeks.
$49.99
CAS 910463-68-2

Semaglutide 6mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Mid-range 6mg vial supports two-vial titration schedules; STEP-1 Phase 3 mean weight reduction −14.9% over 68 weeks.
$79.99
CAS 910463-68-2
Tirzepatide 60mg
$399.99

